IQVIA Holdings Inc. Provides Update on Secondary Offering

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (NYSE: IQV), a leading global provider of advanced
analytics, technology solutions, and contract research services to the
life sciences industry, announced today that in light of recent market
conditions, it and the selling stockholders will not proceed with the
previously announced secondary public offering and concurrent repurchase
of common stock.

IQVIA (NYSE: IQV) is a leading global provider of advanced analytics,
technology solutions, and contract research services to the life
sciences industry. Formed through the merger of IMS Health and
Quintiles, IQVIA applies human data science — leveraging the analytic
rigor and clarity of data science to the ever-expanding scope of human
science — to enable companies to reimagine and develop new approaches to
clinical development and commercialization, speed innovation, and
accelerate improvements in healthcare outcomes. Powered by the IQVIA
CORE™, IQVIA delivers unique and actionable insights at the intersection
of large-scale analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 55,000
employees, IQVIA conducts operations in more than 100 countries.

IQVIAFIN

Click
here to subscribe to Mobile Alerts for IQVIA.

Contacts

IQVIA Holdings Inc.
Media Relations:
Tor Constantino,
484-567-6732
tor.constantino@iqvia.com
or
Investor
Relations:
Andrew Markwick, 973-257-7144
andrew.markwick@iqvia.com